default author photo

Prashanth Prithviraj

affiliation not provided to SSRN

SCHOLARLY PAPERS

1

DOWNLOADS

43

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Pembrolizumab and Denosumab in clear-cell renal-cell carcinoma

Number of pages: 28 Posted: 15 Dec 2025
affiliation not provided to SSRN, The University of Sydney - NHMRC Clinical Trials Centre, affiliation not provided to SSRN, The University of Western Australia - Fiona Stanley Hospital, affiliation not provided to SSRN, University of Queensland, Border Medical Oncology, Monash Health, affiliation not provided to SSRN, Flinders University, affiliation not provided to SSRN, The University of Sydney - NHMRC Clinical Trials Centre, Macquarie University, The Kinghorn Cancer Centre, Peter MacCallum Cancer Centre, affiliation not provided to SSRN, affiliation not provided to SSRN, The University of Sydney - NHMRC Clinical Trials Centre, Monash University and affiliation not provided to SSRN
Downloads 43 (1,145,425)

Abstract:

Loading...

renal cell carcinoma, Immune checkpoint inhibitors, RANKL inhibition, clinical trial, pembrolizumab, denosumab